Drugs / PIA0601
last change Jan 2007 re-read 3 minutes ago

PIA0601

also known as Trivalent DNA Vaccine

Vaccine

Developed for
influenza
Investigated by
PowderMed

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00375206 Sep 2006 → Jan 2007 influenza PowderMed Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PIA0601 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00375206 ↗
Known as Trivalent DNA Vaccine “Trivalent DNA Vaccine (PIA0601) with or without DEI-LT (pPJV2012)” NCT00375206 ↗
Modality Vaccine “particle mediated epidermal delivery (PMED) trivalent DNA vaccine” NCT00375206 ↗
Route Other “Administered by Particle Mediated Epidermal Delivery (PMED)” NCT00375206 ↗